Shanthi Vandrangi

Shanthi Vandrangi, PhD, is a seasoned leader in clinical affairs with a notable track record in evidence generation and clinical trials. As the Director of Emerging Therapies at Stryker since January 2024, Shanthi has successfully led global strategies that resulted in over 100 peer-reviewed manuscripts and 150 podium presentations, significantly impacting clinical guidelines and category leadership. Prior experience includes significant roles at Inari Medical and Edwards Lifesciences, where Shanthi was recognized for driving scientific strategies, executing pivotal clinical trials, and enhancing brand visibility through late-breaking presentations. An academic background rooted in bioengineering and biomedical engineering, coupled with teaching experience at the University of California, Riverside, reinforces Shanthi’s expertise in the field.